🇺🇸 FDA

Intelligence · Patent portfolio

Prime Medicine Patents

Full USPTO pharma patent portfolio for Prime Medicine — grant dates, expiration, and drug cross-links.

Patents
127
Expiring ≤24m
1

Quick answer

Prime Medicine has 127 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12404275

    Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383582

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12377115

    Combination immunotherapies for treatment of cancer

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12365719

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12319738

    Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12304898

    Quinolyl-containing compound and pharmaceutical composition, and use thereof

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12233119

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12234302

    Chitosan derivatives and methods for preparing the same

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12195535

    Antibodies binding to VISTA at acidic pH

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12194090

    Tetanus vaccine platform for embedding COVID-19 vaccine

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12173069

    Antibodies binding to vista at acidic pH

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12150445

    Method and composition for hypothermic storage of placental tissue

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12129258

    Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12091462

    Antibodies binding to vista at acidic pH

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12059443

    Method for treating cancer using dengue virus serotype 1 (DENV-1)

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11975046

    Medical use of interferon-lambda for the treatment of fibrosis

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11957740

    Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11939383

    B7-H4 antibodies and methods and use thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11896623

    Visco-supplement compositions, and methods of use thereof

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11814431

    B7-H4 antibodies and methods of use thereof

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11781247

    Variable epitope library compositions and methods of therapeutic and prophylactic use

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11771752

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11666606

    Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11603406

    Antibodies binding to VISTA at acidic pH

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11566076

    Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11559583

    Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11535684

    Chitosan derivatives and methods for preparing the same

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11491190

    Visco-supplement compositions, and methods of use thereof

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11426486

    Chitosan-containing formulations

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11421034

    Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11401328

    Antibodies binding to ILT4

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11389497

    Pharmaceutical composition for treating cancer

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11357795

    Combination immunotherapies for treatment of cancer

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11324760

    Solid dispersion of dutasteride, method for preparing the solid dispersion, and pharmaceutical composition including the solid dispersion

    Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11306144

    B7-H4 antibodies and methods of use thereof

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11306150

    Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11235059

    Afucosylated anti-FGFR2IIIB antibodies

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11186646

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11166924

    N-methyl-d-aspartate receptor allosteric modulators and methods for their use

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11129856

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11098103

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11091555

    Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11083758

    Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11071778

    Combination product for use in tumor vaccination

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11052144

    Methods of tumor vaccination

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11040090

    Botulinum neurotoxin compositions

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11027001

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10982001

    Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Prime Medicine have?

127 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Prime Medicine patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.